Novavax begins Phase III clinical trial for influenza vaccine NanoFlu
US-based late-stage biotechnology company Novavax has started a pivotal Phase III clinical trial for its influenza vaccine, NanoFlu. NanoFlu is…
US-based late-stage biotechnology company Novavax has started a pivotal Phase III clinical trial for its influenza vaccine, NanoFlu. NanoFlu is…
US antiviral drugmaker Gilead Sciences and Belgo-Dutch biotech Galapagos have announced week 52 data from the Phase III FINCH 1…
Clinical-stage biopharmaceutical company Anavex Life Sciences has initiated a long-term extension study for patients with early Alzheimer’s disease (AD) and…
Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab and PARP inhibitor pamiparib. The…
Boehringer Ingelheim has presented data that shows the Phase III INBUILD trial of nintedanib met its primary endpoint. The drug…
AstraZeneca has announced that new data from a Phase IV independent trial, TWILIGHT, showed BRILINTA (ticagrelor) monotherapy reduces the possibility…
Biotechnology company Enanta Pharmaceuticals has reported positive results from its ARGON-1 Phase 2a study of its lead product candidate EDP-305…
Denmark-based biotechnology company Zealand Pharma has reported positive outcome for its dasiglucagon in the paediatric Phase 3 trial for severe…
Coordination Pharmaceuticals (CPI) has dosed the first patient in a Phase I study of nanoscale coordination polymer (NCP) CPI-200 in…
Researchers at Cincinnati Children’s Hospital Medical Center in the US have designed and tested a new computerised solution which uses…